Skip to main content

Table 1 Patients’ demographic and clinical characteristics

From: Plasma circulating tumor DNA assessment reveals KMT2D as a potential poor prognostic factor in extranodal NK/T-cell lymphoma

Prognostic variables

No.

Proportion(%)

Gender

 Male

45

69.23

 Female

20

30.77

Clinical stage

 I

14

21.54

 II

20

30.77

 III

13

20.00

 IV

18

27.69

B symptoms

 With

26

40.00

 Without

39

60.00

IPI Scores

 1

22

33.85

 2

24

36.92

 3

14

21.54

 4

5

7.69

Final Recurrence status

 With

9

13.85

 Without

56

86.15

Ki67 index

 Low

33

50.77

 High

32

49.23